Login to Your Account

MedImmune Enters Licensing Deals For Two Cancer Products

By Kim Coghill

Monday, April 22, 2002
MedImmune Inc. agreed to spend an undisclosed amount of money expanding its cancer program through the licensure of two early stage technologies. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription